Gene therapy for advanced lymphoma gets FDA approval

People with advanced lymphoma now have another type of treatment to consider. The Food and Drug Administration has approved Yescarta, a cell-based gene therapy designed to treat large B-cell lymphoma created by Kite Pharma. It’s the second time the FDA has approved a gene therapy for use in the US following a procedure meant to […]

An 'exciting' cancer treatment may be on the horizon for leukaemia and lymphoma sufferers

The FDA yesterday showed enthusiasm for the treatment which uses patients’ revved-up immune cells to fight cancer. A unanimous recommendation from the Oncologic Drugs Advisory Committee means it could be approved by the end of September. Timothy Cripe, a panel member who is an oncologist with Nationwide Children’s Hospital in Columbus, Ohio, called the treatment […]